Vitamin C in Post-cardiac Arrest
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 270 participants.
Also called NCT03509662
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 270 participants
- Registry
-
NCT03509662
-
- Other papers using this trial's data
- Early high-dose vitamin C for out-of-hospital cardiac arrest: the VITaCCA randomized clinical trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT03509662. Randomized; quadruple masking; primary purpose treatment. Start 2019-10-07 (actual); primary completion 2024-02-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vitamin C in Post-cardiac Arrest
- Acronym
- VITaCCA
- Condition
- Cardiac Arrest
- Intervention (Drug)
- Vitamin C
- Intervention (Drug)
- Thiamine
- Intervention (Drug)
- Placebos
- Lead sponsor
- Amsterdam UMC, location VUmc
- Collaborator
- Gelderse Vallei Hospital
- Collaborator
- Sint Franciscus Gasthuis
- Collaborator
- Tergooiziekenhuizen
- Collaborator
- Amphia Hospital
- Collaborator
- Erasmus Medical Center
- Collaborator
- Noordwest Ziekenhuisgroep
- Collaborator
- Maasstad Hospital
- Collaborator
- OLVG
Record details
- Record id
cardio:ct-nct03509662- Content hash
0b25d9868d597e12292380d17fa9154ac7336aa3a841061f04f71cfd97883021